
Koios Medical: Leading software medical device provider, revolutionizing healthcare with machine support.
Koios Medical, founded with the mission to revolutionize healthcare through advanced machine learning, specializes in AI-powered software for cancer diagnosis. Their core products, Smart Ultrasound® Software, are FDA-cleared and CE-marked, focusing on breast and thyroid cancer. The company aims to support physicians in delivering exceptional care by providing tools that enable confident diagnoses in seconds. Their market focus is on enhancing diagnostic accuracy and efficiency in medical practices globally.
Notable affiliated individuals include experts in healthcare technology and AI, contributing to the company's innovative edge. Koios Medical has attracted significant investment to advance its groundbreaking software solutions. Key achievements include regulatory approvals and the successful integration of their software into clinical settings, demonstrating substantial improvements in diagnostic accuracy and workflow efficiency. Overall, Koios Medical has made a significant impact on the healthcare industry by leveraging AI to improve patient outcomes and support medical professionals.

EchoNous
echonous.com

BioticsAI
biotics.ai

Osia Medical

iSono Health
isonohealth.com

Mrimath

Oncora Medical
oncoramedical.com

Cura AI
cura-ai.co

Koya Medical
koyamedical.com

Clearview Diagnostics

Onc.AI
onc.ai

RAD AI
radai.com

Sanus Solutions
sanussolutions.com

Sway Medical
swaymedical.com

Kjaya

Helio Health
heliohealth.com
Companies similar to Koios Medical include EchoNous, BioticsAI, Osia Medical and iSono Health.
Koios Medical was founded in 2012.
Koios Medical's headquarters is located in New York City, NY, US.
Koios Medical's most recent funding round was for $8M (USD) in February 2023.
As of Feb 17, 2023, Koios Medical has raised a total of $13M (USD).
Koios Medical has 46 employees as of Feb 5, 2024.